肌肉质量悖论:肌肉质量指数升高会通过心肌重塑来损害心功能,而肥胖患者则会通过心肌重塑来损害心功能
Hailong Zhang1, Jiali Fan2, Rui Han1
1Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Echocardiography (Mount Kisco, N.Y.)
|September 8, 2025
概括
肥胖的人通常有心脏功能受损. 骨肌肉质量指数 (SMI) 和无脂肪质量指数 (FFMI) 是肥胖症中这种亚临床缩功能障碍的关键预测指标.
科学领域:
- 心脏病学 心脏病学
- 肥胖医学 肥胖医学
- 身体组成分析 身体成分分析
背景情况:
- 肥胖与心血管并发症有关.
- 亚临床心脏功能障碍是肥胖人口心脏病的早期指标.
- 了解肥胖心脏功能障碍的预测因素对于早期干预至关重要.
研究的目的:
- 研究肥胖的年轻成年人身体组成和心脏功能之间的关系.
- 为了确定亚临床左心室缩功能障碍的预测因素.
- 为了比较代谢健康肥胖 (MHO) 和代谢不健康肥胖 (MUO) 组之间的心脏参数.
主要方法:
- 在91名肥胖参与者和20名对照人群中使用心声和身体成分分析.
- 全球纵向应变 (GLS) <18%定义的亚临床左心室缩功能障碍.
- 评估了人体测量,血清学和代谢资料.
主要成果:
- 与对照组相比,肥胖的参与者 (MHO和MUO) 呈现出心肌纵向应变的减少.
- 很大一部分肥胖个体 (34.07%) 呈现出受损的GLS.
- 较高的骨肌肉质量指数 (SMI) 和无脂肪质量指数 (FFMI) 与GLS受损相关.
结论:
- 亚临床缩功能障碍,指的是GLS受损,在肥胖个体中很普遍.
- SMI和FFMI被确定为肥胖人口中GLS受损的独立预测因素.
- 这些发现凸显了身体组成在评估肥胖心脏健康方面的重要性.
更多相关视频
13:35Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
11.5K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
12.1K
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189
Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
211
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
211
